Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

about

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy.

P2860

Q42373183-0BC8B131-501C-4C4D-81DD-D385B30003B3

P2860

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

Item

http://www.wikidata.org/entity/Q38933874

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

@en

type

Item

label

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

@en

prefLabel

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

@en

P1476

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

@en

P2093

Henry P Redmond

http://www.w3.org/2001/XMLSchema#string

Marcel Jinih

http://www.w3.org/2001/XMLSchema#string

Mark A Corrigan

http://www.w3.org/2001/XMLSchema#string

Norma Relihan

http://www.w3.org/2001/XMLSchema#string

Seamus O'Reilly

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474

Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline

A gene-expression signature as a predictor of survival in breast cancer

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

The MINDACT trial: the first prospective clinical validation of a genomic tool

History of aromatase: saga of an important biological mediator and therapeutic target

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

P31

scholarly article

P356

10.1111/TBJ.12783

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28252242

http://www.w3.org/2001/XMLSchema#string

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

about

P2860

P2860

Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698